Clinical trial
TNF-alpha Directed Therapy in Asthma
NCT00278083 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00278083 |
|---|---|
| Title | TNF-alpha Directed Therapy in Asthma |
| Official title | A Randomised, Double Blind, Placebo-controlled, Parallel Group Pilot Study to Determine the Effect of REMICADE on Safety, Efficacy and Biomarkers of Inflammation in Patients With Asthma Receiving Inhaled Corticosteroids |
| Lead sponsor | Imperial College London, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug, Procedure |
| Interventions | Study drug administration, Tuberculin intradermal skin test, Lung function test for FEV1, Asthma symptom scores diary, Quality of life diary, Breath nitric oxide, Breath condensate, Sputum induction, Blood sampling, Urinalysis |
| Enrollment | 40 |
| Start date | Oct 1, 2001 |
| Completion | Apr 1, 2004 |
| First posted | Jan 18, 2006 |
| Last update posted | Sep 14, 2023 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: